IL153641A0 - Human myeloma cell line - Google Patents

Human myeloma cell line

Info

Publication number
IL153641A0
IL153641A0 IL15364101A IL15364101A IL153641A0 IL 153641 A0 IL153641 A0 IL 153641A0 IL 15364101 A IL15364101 A IL 15364101A IL 15364101 A IL15364101 A IL 15364101A IL 153641 A0 IL153641 A0 IL 153641A0
Authority
IL
Israel
Prior art keywords
myeloma cell
cell line
human myeloma
human
producing
Prior art date
Application number
IL15364101A
Other languages
English (en)
Original Assignee
Univ Cambridge Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016824A external-priority patent/GB0016824D0/en
Priority claimed from GB0017139A external-priority patent/GB0017139D0/en
Application filed by Univ Cambridge Tech filed Critical Univ Cambridge Tech
Publication of IL153641A0 publication Critical patent/IL153641A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • C12N5/163Animal cells one of the fusion partners being a B or a T lymphocyte
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15364101A 2000-07-07 2001-07-09 Human myeloma cell line IL153641A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016824A GB0016824D0 (en) 2000-07-07 2000-07-07 Human monoclonal antibodies
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
US27058801P 2001-02-23 2001-02-23
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Publications (1)

Publication Number Publication Date
IL153641A0 true IL153641A0 (en) 2003-07-06

Family

ID=27255800

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15364101A IL153641A0 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Country Status (12)

Country Link
US (1) US7387873B2 (de)
EP (1) EP1299524B1 (de)
JP (1) JP2004502454A (de)
KR (1) KR20030022850A (de)
CN (1) CN100497601C (de)
AT (1) ATE440945T1 (de)
AU (2) AU2001269300B2 (de)
CA (1) CA2415484A1 (de)
DE (1) DE60139694D1 (de)
IL (1) IL153641A0 (de)
NO (1) NO20030019L (de)
WO (1) WO2002004607A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030022850A (ko) 2000-07-07 2003-03-17 캠브리지 유니버시티 테크니칼 서비스 리미티드 인간 골수종 세포주
WO2003052082A2 (en) 2001-12-18 2003-06-26 Whitehead Institute For Biomedical Research Fusion partner cells and uses thereof
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8460745B2 (en) * 2009-09-20 2013-06-11 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
CN105601734A (zh) * 2016-03-01 2016-05-25 广东医学院附属医院 一种从人外周血记忆性b淋巴细胞制备抗体的方法
CN115463146B (zh) * 2022-10-14 2024-01-23 浙大城市学院 哇巴因化合物作为在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379055D1 (en) * 1982-06-09 1989-03-02 Asahi Chemical Ind Method for producing human antibody
US4720459A (en) * 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
KR20030022850A (ko) 2000-07-07 2003-03-17 캠브리지 유니버시티 테크니칼 서비스 리미티드 인간 골수종 세포주

Also Published As

Publication number Publication date
US20040023339A1 (en) 2004-02-05
AU6930001A (en) 2002-01-21
WO2002004607A1 (en) 2002-01-17
AU2001269300B2 (en) 2006-06-22
CA2415484A1 (en) 2002-01-17
EP1299524B1 (de) 2009-08-26
EP1299524A1 (de) 2003-04-09
ATE440945T1 (de) 2009-09-15
NO20030019D0 (no) 2003-01-03
KR20030022850A (ko) 2003-03-17
US7387873B2 (en) 2008-06-17
NO20030019L (no) 2003-03-07
DE60139694D1 (de) 2009-10-08
CN100497601C (zh) 2009-06-10
CN1455813A (zh) 2003-11-12
JP2004502454A (ja) 2004-01-29

Similar Documents

Publication Publication Date Title
YU28503A (sh) Humanizovana anti-lt-beta-r antitela
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
IL161705A0 (en) Human monoclonal antibodies to dendritic cells
EP1519747A4 (de) Menschliche monoklonale antikörper gegen prostata-spezifisches membranantigen (psma)
HUP0402066A3 (en) Cells producing antibody compositions
EP1304754A4 (de) Herstellungsverfahren für elektrolyt-filmelektroden-verbindungen
AU2003257850A8 (en) Antibody specific to central tau-protein
HK1078589A1 (en) Anti-human tenascin monoclonal antibody
EP1881064A3 (de) Monoklonale HCV-Kern-Antikörper
AU6930001A (en) Human myeloma cell line
ZA200007458B (en) Method of preparing a fuel cell.
EP1227159A4 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
EP1178829A4 (de) Menschlicher monoklonaler antikörper
BR0015872A (pt) Agentes antitrombóticos
IL139217A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
EP1700122A4 (de) Immunoassays, haptene, immunogene und antikörper für anti-hiv-therapeutika
AU2001280368A1 (en) Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy
WO2004029069A3 (en) Hybridomas producing high levels of human sequence antibody
AU2001249546A1 (en) Methods for treating disease with antibodies to cxcr3
NO20015285D0 (no) Fremstillingsprosess for n¶ringsmiddelfermenterende midler
AU5664601A (en) A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
AU2001254864A1 (en) Cell culture method, cell cluster obtained by said methods and use thereof
GB0017139D0 (en) Human monoclonal antibodies
GB0003359D0 (en) Monoclonal antibodies
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2